Innoviva (INVA) Return on Sales (2016 - 2025)
Innoviva's Return on Sales history spans 16 years, with the latest figure at 0.51% for Q4 2025.
- For Q4 2025, Return on Sales rose 905.0% year-over-year to 0.51%; the TTM value through Dec 2025 reached 0.51%, up 55.0%, while the annual FY2025 figure was 0.66%, 63.0% up from the prior year.
- Return on Sales reached 0.51% in Q4 2025 per INVA's latest filing, down from 0.83% in the prior quarter.
- In the past five years, Return on Sales ranged from a high of 102.9% in Q1 2021 to a low of 94.89% in Q1 2025.
- Average Return on Sales over 5 years is 13.17%, with a median of 0.94% recorded in 2025.
- The largest YoY upside for Return on Sales was 10190bps in 2021 against a maximum downside of -27484bps in 2021.
- A 5-year view of Return on Sales shows it stood at 6.12% in 2021, then crashed by -61bps to 9.83% in 2022, then soared by 56bps to 4.3% in 2023, then plummeted by -98bps to 8.53% in 2024, then skyrocketed by 106bps to 0.51% in 2025.
- Per Business Quant, the three most recent readings for INVA's Return on Sales are 0.51% (Q4 2025), 0.83% (Q3 2025), and 0.64% (Q2 2025).